Skip to content

Neurotoxin and Physical Therapy

Synergistic Effects of Neurotoxin and Physical Therapy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02177617
Enrollment
16
Registered
2014-06-27
Start date
2014-12-31
Completion date
2017-01-07
Last updated
2023-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Dystonia

Keywords

Cervical Dystonia, Botox

Brief summary

This study aims to compare Botox injections without Physical Therapy sessions to Botox injections combined with Physical Therapy sessions for treatment of Cervical Dystonia. It is expected that Botox combined with Physical Therapy will improve Cervical Dystonia symptoms and quality of life more than Botox alone. It is also expected that Botox combined with Physical Therapy will enhance neuroplasticity, or the ability of the brain to make new connections, more than Botox alone at 4-5 weeks, and remain improved at 12 weeks, after Botox injection.

Detailed description

The study will recruit primary cervical dystonia patients (age 18-80) who are stable on Allergan botulinum toxin type A (Botox). Patients will be randomized to receive their typical Botox injection alone, or with physical therapy. At Baseline, disease characteristics (as measured by the Toronto Western Spasmodic Torticollis Rating Scale, or TWSTRS, and the Clinical Global Impression of Severity, or CGIS) will be measured, along with quality of life (from the Short Health 36 Survey Form 36, or SF-36). One subscale of the TWSTRS will be videotaped to be later evaluated by blinded movement disorder specialists. A pain scale will also be completed and range of head motion will be measured using a device similar to a protractor (called a goniometer). An individualized Botox injection will be administered, as well as transcranial magnetic stimulation (TMS) to measure neuroplasticity, or the ability of the brain to make new connections. If randomized to receive physical therapy, participants will also receive instructions to perform physical therapy exercises five times per week by a physical therapist who specializes in movement disorders. The investigator will call weekly to check how the participant is doing with the exercise program. The same procedures outlined above will also be performed at 5 weeks past baseline, and at 12 weeks (except for the Botox injection, which will only be given at baseline and 12 weeks).

Interventions

Participants will receive a tailored dose of Botox to address their Cervical Dystonia symptoms

BEHAVIORALPhysical Therapy

Participants will undergo physical therapy sessions with a physical therapist trained in movement disorders. Participants will be instructed to continue these exercises five times per week, and will be called weekly by the investigator to check progress.

PROCEDURETranscranial magnetic stimulation (TMS)

For these tests, participants will sit in a chair that looks like one found at the dentist's office. A nerve stimulator will be placed on the wrist of the right hand to stimulate the median and ulnar nerves. The intensity of the nerve stimulator will be gradually increased until the right thumb begins to twitch. A magnetic coil will be placed on the scalp on the left side of the head, overlying the brain's motor cortex, to stimulate the brain's output to the muscles in the opposite hand. This procedure will be repeated using the left wrist and the right side of the head.

Sponsors

American Academy of Neurology
CollaboratorOTHER
National Ataxia Foundation
CollaboratorOTHER
American Brain Foundation
CollaboratorOTHER
University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18-80 with a diagnosis of Cervical Dystonia, which will be confirmed by a movement disorders specialist * Positive response to at least two prior treatments with Botox as indicated by an improvement in Clinical Global Improvement Scale. * Received last dose of Botox a minimum of 12 weeks prior to baseline visit.

Exclusion criteria

* Any conditions that would contraindicate transcranial magnetic stimulation (for example, pregnancy or epilepsy) * Any secondary, fixed, post-traumatic, or psychogenic dystonia

Design outcomes

Primary

MeasureTime frameDescription
Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)absolute value at Week 12The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) is a measure of symptoms, pain, and disability related to Cervical Dystonia. The total TWSTRS scale includes a global outcome score (total score) and scores on each of 3 subscales for severity (0-35), disability (0-30), and pain (0-20), which are summed together for a total score (0-85), with higher scores indicating greater impairment. The TWSTRS is completed by a neurologist who visually assesses the patient's symptoms, and asks the patient to self-report on pain and disability.
SF-36 Physical Functioning Subscoreabsolute value at Week 12The Short Form 36-Item Health Scale (SF-36) is a health survey with 36 questions that is self-reported by the study participant. It contains 8 subscales, one of which is Physical Functioning, calculated from 10 of the 36 questions. Different questions have different score ranges and valences. Therefore, their response for each question is linearly transformed to a value of 0-100 (for example, choosing response 3 on a scale of 1-5 is transformed to 60). These ten values are then averaged to generate the Physical Functioning subscore, ranging from 0-100. The higher the response value and the subscore, the higher degree of physical functioning. More details on RAND SF-36 scoring here: https://www.rand.org/health-care/surveys\_tools/mos/36-item-short-form/scoring.html
Clinical Global Impression Scale (CGIS)absolute value at Week 12This scale is an investigator-rated scale that measures illness severity on a single 7-point scale (1-7). Higher scores represent greater severity of illness.

Secondary

MeasureTime frameDescription
Mean MEP After Paired Associative Stimulation (PASmean)absolute value at week 12A standard transcranial magnetic stimulation (TMS) paired associative stimulation (PAS) protocol was used to measure of neuroplasticity (the ability of the brain to form new connections). A nerve stimulator was placed on the wrist of the right hand to stimulate the median and ulnar nerves, set at the lowest intensity where the right thumb begins to twitch. An EMG sensor was placed over the abductor pollicis brevis muscle to measure muscle contractions. A magnetic coil was placed on the scalp on the left side of the head, overlying the brain's motor cortex, to stimulate the brain's output to the muscles in the opposite hand. 90 pairs of TMS and nerve stimulator pulses were applied. Then the motor evoked potential (MEP) from a single TMS pulse recorded from the surface EMG of the abductor pollicis brevis muscle was determined immediately, at 15 min and at 30 min after completion of the PAS protocol. The mean of these MEPs (PASmean) was compared between baseline and followup.

Other

MeasureTime frameDescription
Visual Analog Scaleabsolute value at 12 weeksThis is a single item scale, on which participants will mark the level of pain from 0-10. Higher score represents more severe pain.
Cervical Range of Motion Measurementabsolute value at 12 weeks was calculatedParticipants will be asked to sit in a chair and move the head to the left, to the right, to the front, and to the back. Then, participants be asked to tilt the head from side to side. A goniometer will be used to measure how far the head is able to move. The goniometer is similar to a protractor that measures magnitude of angle. A greater number indicates a greater range of motion. The minimum score would be 0, with no definite maximum (would not clinically be expected to exceed 70 degrees).

Countries

United States

Participant flow

Participants by arm

ArmCount
Botox Only
Participants randomized to receive Botox injections alone. Botox injection: Participants will receive a tailored dose of Botox to address their Cervical Dystonia symptoms Transcranial magnetic stimulation (TMS): For these tests, participants will sit in a chair that looks like one found at the dentist's office. A nerve stimulator will be placed on the wrist of the right hand to stimulate the median and ulnar nerves. The intensity of the nerve stimulator will be gradually increased until the right thumb begins to twitch. A magnetic coil will be placed on the scalp on the left side of the head, overlying the brain's motor cortex, to stimulate the brain's output to the muscles in the opposite hand. This procedure will be repeated using the left wrist and the right side of the head.
8
Botox Plus Physical Therapy
Participants randomized to receive Botox injection combined with Physical Therapy Botox injection: Participants will receive a tailored dose of Botox to address their Cervical Dystonia symptoms Physical Therapy: Participants will undergo physical therapy sessions with a physical therapist trained in movement disorders. Participants will be instructed to continue these exercises five times per week, and will be called weekly by the investigator to check progress. Transcranial magnetic stimulation (TMS): For these tests, participants will sit in a chair that looks like one found at the dentist's office. A nerve stimulator will be placed on the wrist of the right hand to stimulate the median and ulnar nerves. The intensity of the nerve stimulator will be gradually increased until the right thumb begins to twitch. A magnetic coil will be placed on the scalp on the left side of the head, overlying the brain's motor cortex, to stimulate the brain's output to the muscles in the opposite hand. This procedure will be repeated using the left wrist and the right side of the head.
8
Total16

Baseline characteristics

CharacteristicTotalBotox Plus Physical TherapyBotox Only
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
10 Participants5 Participants5 Participants
Age, Categorical
Between 18 and 65 years
6 Participants3 Participants3 Participants
Age, Continuous64.5 years
STANDARD_DEVIATION 5.5
64.7 years
STANDARD_DEVIATION 5.4
64.3 years
STANDARD_DEVIATION 5.2
Region of Enrollment
United States
16 participants8 participants8 participants
Sex: Female, Male
Female
8 Participants4 Participants4 Participants
Sex: Female, Male
Male
8 Participants4 Participants4 Participants
TWSTRS pain3.8 units on a scale
STANDARD_DEVIATION 1.2
3.8 units on a scale
STANDARD_DEVIATION 1.5
4 units on a scale
STANDARD_DEVIATION 1.4

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 8
other
Total, other adverse events
0 / 80 / 8
serious
Total, serious adverse events
0 / 80 / 8

Outcome results

Primary

Clinical Global Impression Scale (CGIS)

This scale is an investigator-rated scale that measures illness severity on a single 7-point scale (1-7). Higher scores represent greater severity of illness.

Time frame: absolute value at Week 12

Population: mean difference was calculated

ArmMeasureValue (MEAN)Dispersion
Botox OnlyClinical Global Impression Scale (CGIS)3 units on a scaleStandard Deviation 1
Botox Plus Physical TherapyClinical Global Impression Scale (CGIS)2 units on a scaleStandard Deviation 1
Primary

SF-36 Physical Functioning Subscore

The Short Form 36-Item Health Scale (SF-36) is a health survey with 36 questions that is self-reported by the study participant. It contains 8 subscales, one of which is Physical Functioning, calculated from 10 of the 36 questions. Different questions have different score ranges and valences. Therefore, their response for each question is linearly transformed to a value of 0-100 (for example, choosing response 3 on a scale of 1-5 is transformed to 60). These ten values are then averaged to generate the Physical Functioning subscore, ranging from 0-100. The higher the response value and the subscore, the higher degree of physical functioning. More details on RAND SF-36 scoring here: https://www.rand.org/health-care/surveys\_tools/mos/36-item-short-form/scoring.html

Time frame: absolute value at Week 12

Population: mean difference between two groups calculated

ArmMeasureValue (MEAN)Dispersion
Botox OnlySF-36 Physical Functioning Subscore68 units on a scaleStandard Deviation 16
Botox Plus Physical TherapySF-36 Physical Functioning Subscore88 units on a scaleStandard Deviation 18
Primary

Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)

The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) is a measure of symptoms, pain, and disability related to Cervical Dystonia. The total TWSTRS scale includes a global outcome score (total score) and scores on each of 3 subscales for severity (0-35), disability (0-30), and pain (0-20), which are summed together for a total score (0-85), with higher scores indicating greater impairment. The TWSTRS is completed by a neurologist who visually assesses the patient's symptoms, and asks the patient to self-report on pain and disability.

Time frame: absolute value at Week 12

Population: mean difference between two groups was calculated

ArmMeasureValue (MEAN)Dispersion
Botox OnlyToronto Western Spasmodic Torticollis Rating Scale (TWSTRS)28 total score on a scaleStandard Deviation 10.2
Botox Plus Physical TherapyToronto Western Spasmodic Torticollis Rating Scale (TWSTRS)20.1 total score on a scaleStandard Deviation 9.8
Secondary

Mean MEP After Paired Associative Stimulation (PASmean)

A standard transcranial magnetic stimulation (TMS) paired associative stimulation (PAS) protocol was used to measure of neuroplasticity (the ability of the brain to form new connections). A nerve stimulator was placed on the wrist of the right hand to stimulate the median and ulnar nerves, set at the lowest intensity where the right thumb begins to twitch. An EMG sensor was placed over the abductor pollicis brevis muscle to measure muscle contractions. A magnetic coil was placed on the scalp on the left side of the head, overlying the brain's motor cortex, to stimulate the brain's output to the muscles in the opposite hand. 90 pairs of TMS and nerve stimulator pulses were applied. Then the motor evoked potential (MEP) from a single TMS pulse recorded from the surface EMG of the abductor pollicis brevis muscle was determined immediately, at 15 min and at 30 min after completion of the PAS protocol. The mean of these MEPs (PASmean) was compared between baseline and followup.

Time frame: absolute value at week 12

Population: mean difference was calculated

ArmMeasureValue (MEAN)Dispersion
Botox OnlyMean MEP After Paired Associative Stimulation (PASmean)1.7 millivoltsStandard Deviation 0.5
Botox Plus Physical TherapyMean MEP After Paired Associative Stimulation (PASmean)1.3 millivoltsStandard Deviation 0.6
Other Pre-specified

Cervical Range of Motion Measurement

Participants will be asked to sit in a chair and move the head to the left, to the right, to the front, and to the back. Then, participants be asked to tilt the head from side to side. A goniometer will be used to measure how far the head is able to move. The goniometer is similar to a protractor that measures magnitude of angle. A greater number indicates a greater range of motion. The minimum score would be 0, with no definite maximum (would not clinically be expected to exceed 70 degrees).

Time frame: absolute value at 12 weeks was calculated

Population: mean difference was calculated

ArmMeasureValue (MEAN)Dispersion
Botox OnlyCervical Range of Motion Measurement25 Angle in degreesStandard Deviation 14
Botox Plus Physical TherapyCervical Range of Motion Measurement26 Angle in degreesStandard Deviation 14
Other Pre-specified

Visual Analog Scale

This is a single item scale, on which participants will mark the level of pain from 0-10. Higher score represents more severe pain.

Time frame: absolute value at 12 weeks

Population: mean difference was calculated

ArmMeasureValue (MEAN)Dispersion
Botox OnlyVisual Analog Scale6 units on a scaleStandard Deviation 3
Botox Plus Physical TherapyVisual Analog Scale4 units on a scaleStandard Deviation 2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026